AGILENT TECHNOLOGIES, INC. Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount
AGILENT TECHNOLOGIES, INC. (A) reported Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount of $5.00 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-01.
Financial Statements › Notes › Debt and Equity Securities › Equity Securities without Readily Determinable Fair Value, Annual Amount
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount · last filed 2026-09-01
- AGILENT TECHNOLOGIES, INC. equity securities without readily determinable fair value, downward price adjustment, annual amount for the quarter ending 2026-07-31 was $5.00M, a 150.00% increase year-over-year.
- AGILENT TECHNOLOGIES, INC. equity securities without readily determinable fair value, downward price adjustment, annual amount for the quarter ending 2026-04-30 was $1.00M, a 96.15% decline year-over-year.
- AGILENT TECHNOLOGIES, INC. equity securities without readily determinable fair value, downward price adjustment, annual amount for the quarter ending 2026-01-31 was $0.00, a 100.00% decline year-over-year.
- AGILENT TECHNOLOGIES, INC. equity securities without readily determinable fair value, downward price adjustment, annual amount for the quarter ending 2025-07-31 was $2.00M.
- AGILENT TECHNOLOGIES, INC. equity securities without readily determinable fair value, downward price adjustment, annual amount for fiscal 2025 was $41.00M, a 4000.00% increase from fiscal 2024.
- AGILENT TECHNOLOGIES, INC. equity securities without readily determinable fair value, downward price adjustment, annual amount for fiscal 2024 was $1.00M, a 96.15% decline from fiscal 2023.
- AGILENT TECHNOLOGIES, INC. equity securities without readily determinable fair value, downward price adjustment, annual amount for fiscal 2023 was $26.00M.
| Period end | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 3 month | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 6 month | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 9 month | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 12 month |
|---|---|---|---|---|
| 2026-07-31 | $5.00M 10-Q · filed 2026-09-01 | $6.00M 10-Q · filed 2026-09-01 | ||
| 2026-04-30 | $1.00M 10-Q · filed 2026-06-01 | $1.00M 10-Q · filed 2026-06-01 | ||
| 2026-01-31 | $0.00 10-Q · filed 2026-03-03 | |||
| 2025-10-31 | $41.00M 10-K · filed 2025-12-22 | |||
| 2025-07-31 | $2.00M 10-Q · filed 2026-09-01 | $29.00M 10-Q · filed 2026-09-01 | ||
| 2025-04-30 | $26.00M 10-Q · filed 2026-06-01 | $27.00M 10-Q · filed 2026-06-01 | ||
| 2025-01-31 | $1.00M 10-Q · filed 2026-03-03 | |||
| 2024-10-31 | $1.00M 10-K · filed 2025-12-22 | |||
| 2024-07-31 | $0.00 10-Q · filed 2025-08-29 | $0.00 10-Q · filed 2025-08-29 | ||
| 2024-04-30 | $0.00 10-Q · filed 2025-06-02 | $0.00 10-Q · filed 2025-06-02 | ||
| 2024-01-31 | $0.00 10-Q · filed 2025-03-03 | |||
| 2023-10-31 | $26.00M 10-K · filed 2025-12-22 | |||
| 2023-07-31 | $0.00 10-Q · filed 2024-08-30 | $0.00 10-Q · filed 2024-08-30 | ||
| 2023-04-30 | $0.00 10-Q · filed 2024-06-03 | $0.00 10-Q · filed 2024-06-03 | ||
| 2023-01-31 | $0.00 10-Q · filed 2024-03-05 | |||
| 2022-04-30 | $0.00 10-Q · filed 2023-05-26 | $0.00 10-Q · filed 2023-05-26 | ||
| 2022-01-31 | $0.00 10-Q · filed 2023-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |